Figure 7From: Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible? Haemoglobin variability and epoetin dose adjustments in simulation B. Correlation between the number of therapy modifications and Hb variability (expressed as delta Hb) in the maintenance phase. N = 25.Back to article page